Predicting the outcome of patients with hepatocellular carcinoma: new approaches beyond established clinical scoring systems
Expert Rev Gastroenterol Hepatol
.
2021 Feb;15(2):111-113.
doi: 10.1080/17474124.2021.1829472.
Epub 2020 Oct 12.
Authors
Matthias Ocker
1
2
,
Daniel Neureiter
3
4
Affiliations
1
Department of Gastroenterology CBF, Charité University Medicine Berlin , Berlin, Germany.
2
Translational Medicine & Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & Co ., Ingelheim, Germany.
3
Institute of Pathology, Paracelsus Medical University/Salzburger Landeskliniken (SALK) , Salzburg, Austria.
4
Cancer Cluster Salzburg, Institute of Pathology , Salzburg, Austria.
PMID:
32985933
DOI:
10.1080/17474124.2021.1829472
No abstract available
Publication types
Editorial
Video-Audio Media
Comment
MeSH terms
Carcinoma, Hepatocellular*
Humans
Liver Neoplasms*
Prognosis